PEB:ASX
Pacific Edge Ltd
A$0.22
0.00%
(0.00) 1D
Nov 16, 1:22:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Mkt. cap
348.73M
Avg. vol.
54.38K
Volume
0.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Mkt. cap
348.73M
Avg. vol.
54.38K
Volume
0.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
9 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
13 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
4 hours ago
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com